Commercial extracts assessed
In a new study, four commercial fucoidan extracts were independently characterised to determine their chemical composition, structural features and bioactivities. Read more
In a new study, four commercial fucoidan extracts were independently characterised to determine their chemical composition, structural features and bioactivities. Read more
A new review paper explores the potential of fucoidan-based nanoparticles to support future colorectal cancer treatments. Read more
Marinova has seen a 33% increase in customers formulating with fucoidan for the functional food and beverage category. Read more
A narrative review examines the role of natural compounds in targeting triple-negative breast cancer and their potential synergistic use to improve therapeutic efficacy while reducing treatment-related toxicity. Read more
Prebiotic validation for Undaria pinnatifida fucoidan is based on published scientific evidence. Read more